Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
12 Cards in this Set
- Front
- Back
|
bioavailability
|
t/ ability of a drug to reach its target cells and produce its effect
|
|
|
chemical name
|
strict chemical nomenclature used for naming drugs established by t/ International Union of Pure and Applied Chemistry (IUPAC)
|
|
|
combination drug 2
|
drug product w/ more than one active generic ingredient /17
|
|
|
controlled substance
|
in t/ US a drug restricted by t/ Comprehensive Drug Abuse Prevention and Control Act. In Canada, a drug subject to guidelines outlined in Part III, Sched G of Canadian Food and Drugs Act
|
|
|
generic name
|
nonproprietary name of a drug assigned by the government
|
|
|
mechanism of action
|
how a drug exerts its effects
|
|
|
pharmacological classification
|
method for organizing drugs on t/ basis of their mechanism of action (how they work pharamacologically)
|
|
|
prototype drug
|
an original, well-understood drug model from which other drugs in a pharmacological class have been developed
|
|
|
restricted drug
|
in Canada, a drug not intended for human use, covered in Part IV, Sched H of the Canadian Food and Drug Act
|
|
|
scheduled drug
|
In t/ US, a term describing a drug placed into one of five catedories (I thruV) based on its potential for misuse or abuse
|
|
|
therapeutical classification
|
method for organizing drugs on t/ basis of their therapeutic usefulness
|
|
|
trade name
|
proprietary name of a drug assigned by the manufacturer; also called the brand name or product name
|
